Skip to main content

Drugs

Ausgabe 16/2023

Inhalt (10 Artikel)

Open Access Leading Article

Alcohol-Associated Liver Disease: Evolving Concepts and Treatments

David Stephen Prince, Emily Nash, Ken Liu

Review Article

Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy

Arun Rajasekaran, Todd J. Green, Matthew B. Renfrow, Bruce A. Julian, Jan Novak, Dana V. Rizk

Open Access Systematic Review

Continued Opioid Use and Adverse Events Following Provision of Opioids for Musculoskeletal Pain in the Emergency Department: A Systematic Review and Meta-Analysis

Qiuzhe Chen, Chris G. Maher, Christopher S. Han, Christina Abdel Shaheed, Chung-Wei Christine Lin, Eileen M. Rogan, Gustavo C. Machado

Open Access AdisInsight Report

Lotilaner Ophthalmic Solution 0.25%: First Approval

Yahiya Y. Syed

AdisInsight Report

Tafolecimab: First Approval

Susan J. Keam

AdisInsight Report

Pozelimab: First Approval

Sheridan M. Hoy

AdisInsight Report

Zuranolone: First Approval

Young-A Heo

Open Access Correction

Correction to: Rozanolixizumab: First Approval

Sheridan M. Hoy

Aktuelle Ausgaben